The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review

Abstract Background The adoption of immune checkpoint inhibitors in combination with tyrosine kinase inhibitors (TKIs) and/or local therapy, including transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC), has been utilized as neoadjuvant or conversion therapy for...

Descrición completa

Detalles Bibliográficos

Principais autores:	Lingbo Hu, Yongfu Xu, Yingli Qiao, Aidong Wang, Caidi He, Rongrong Wang
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2025-12-01
Series:	BMC Cancer
Assuntos:	Immune checkpoint inhibitors Conversion therapy Neoadjuvant therapy Hepatocellular carcinoma Liver resection
Acceso en liña:	https://doi.org/10.1186/s12885-025-15449-2
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!